-
Nowitzki, Bird among eight inductees into FIBA Hall of Fame
-
Stocks fall, oil climbs amid uncertainty over US-Iran talks
-
Iran war means more orders for US defense giants
-
Mexico pyramid shooting was planned attack, officials say
-
Trump's messaging on Iran grows increasingly erratic
-
Churchill Downs buys Preakness for $85 million
-
Unregulated AI like speeding with no steering wheel: AI godfather Hinton
-
Tourists return to Rio viewpoint after shootout scare
-
Maradona's daughter slams 'manipulation' of family by his doctors
-
Abhishek's 135 powers Hyderabad to third straight IPL win
-
Vance still in Washington as uncertainty mounts over US-Iran talks
-
No.1 Jeeno seeks first major win at LPGA Chevron event
-
New batch of World Cup tickets to go on sale
-
Material girl: Madonna offers reward for missing clothes
-
Maker of Argentina's first Oscar-winning film, Luis Puenzo, dies at 80:
-
Rape retrial hears Weinstein 'preyed' on aspiring US actress
-
Arrests, hangings, blackout: Iran cranks up wartime repression
-
Seixas relishes 'steep' challenge at Fleche Wallonne
-
US Fed chair nominee says will not be controlled by Trump
-
Singapore's Tang gets second term at UN's patent agency
-
Taiwan leader postpones Eswatini trip after overflight permits revoked
-
Lula warns will respond after US expels police attache
-
Trailblazer Karren Brady steps down from West Ham role
-
US Fed chair nominee says he will not be controlled by Trump
-
Stocks slip, oil climbs as US-Iran truce expiry looms
-
In Portugal, Lula urges return to multilateralism
-
Sinner wants to use Madrid to boost career Grand Slam chances
-
Renewables key to buffer fossil fuel energy shock: COP31 co-hosts
-
Chery wants to make small electric car in Europe
-
Donovan steps down as Bulls coach
-
US official says gas prices have peaked despite Iran war
-
Pope calls for 'law and justice' on Equatorial Guinea visit
-
Trump's Fed chair pick vows to safeguard independence at confirmation hearing
-
Mideast war lights fire under energy transition plans
-
Trump says Iran violated truce as doubt surrounds peace talks
-
Djibouti president re-election confirmed with 97% of vote
-
Barcelona need leaders to fulfil Flick's Champions League dream
-
Guardiola hints that Rodri will make swift Man City return
-
'We weren't soft, we were skilled': Nowitzki on NBA's European revolution
-
PSG and Luis Enrique sweat on Vitinha ahead of Champions League semis
-
Counting a billion people: Inside India's mega census drive
-
UK tackles electricity price link to world gas amid Mideast war
-
In south Lebanon's Nabatieh, residents fear a return to war
-
Bangladesh fuel crunch forces hours-long wait at the pump
-
Fondness for Francis undimmed one year after pope's death
-
Oil and stocks steady as US-Iran truce expiry looms
-
Downing Street exerted pressure to OK Mandelson: sacked UK official
-
Pope visits Equatorial Guinea on last stop of Africa tour
-
German investor morale lowest in over 3 years on Iran war fallout
-
FedEx faces French 'genocide' complaint over Israel cargoes
Disgraced surgeon on trial in Sweden over windpipe transplants
An Italian doctor who made headlines for pioneering windpipe surgery went on trial in Sweden on Wednesday, charged with assault for performing the experimental procedure.
Paolo Macchiarini won praise in 2011 after claiming to have performed the world's first synthetic trachea transplants using stem cells while he was a surgeon at Stockholm's Karolinska Institute.
The procedure was hailed as a breakthrough in regenerative medicine.
But allegations soon emerged that the risky procedure had been carried out on at least one person who had not been critically ill at the time of the operation.
The 63-year-old appeared in court in a blue suit Wednesday, where he listened to translated audio as prosecutors listed the charges of "aggravated assault" against three patients.
- 'Disregard for science' -
The Karolinska Institute has confirmed that the three individuals have since died, but did not directly link the deaths to the operations.
"Macchiarini has carried out the surgery with complete disregard for science and tried experience," prosecutor Karin Lundstrom-Kron told the court.
As prosecutors presented their case they referenced both external and internal reviews of the case, including one published in 2016 by physician Kjell Asplund, who argued that Macchiarini should never have been employed by Karolinska in the first place.
"It is clear that this method has not worked," prosecutor Jim Westerberg said, adding that Macchiarini had embellished the benefits of the procedure.
Macchiarini, who took notes without showing much emotion, has maintained the operations constituted treatments and not experiments, and denied being criminally responsible.
"He contends that he has performed health care, cured and helped," Macchiarini's lawyer Bjorn Hurtig told AFP during a recess.
The prosecution's presentation of evidence is expected to continue over several days so the defence will likely not be able to present its side until next week.
But Hurtig said they had "high hopes" they would be able to counter the prosecution's evidence.
"There are quite a lot of gaps in that evidence and there is a lot of evidence that we argue are favourable to our view of things," he said.
- Downplayed risks -
In 2013, the Karolinska hospital suspended all transplants and refused to extend Macchiarini's contract as a surgeon.
A year later, several surgeons at the hospital filed a complaint alleging that Macchiarini had downplayed the risks of the procedure.
Macchiarini carried out three surgeries at Karolinska University Hospital in 2011 and 2012, using an artificial windpipe made of plastic and coating it with the patient's own stem cells.
Together with his colleagues, he performed a total of eight such transplants between 2011 and 2014, the five others taking place in Russia.
An external review in 2015 found Macchiarini guilty of research misconduct, but despite sacking him, the Karolinska Institute repeatedly defended him until 2018, when it found him and several other researchers guilty.
The university's principal stepped down over the scandal, as well as a number of other people.
Medical journal The Lancet in 2018 retracted two papers authored by Macchiarini.
The trial, held in the Solna district court near the Karolinska Institute, is scheduled to take place over 13 days.
C.Meier--BTB